glp-1 attorney in louisiana / Ozempic Louisiana Ozempic Lawyer | Injury

We comprehensively mapped the benefits and risks of GLP-1 receptor agonists (GLP-1) (Ozempic, Wegovy, Mounjaro, Zepbound)

Between-study heterogeneity was very high (I = 99.21%) although sensitivity analysis revealed that the findings were robust

There have been concerns that GLP-1RAs may increase the risk of intestinal obstruction

GLP-1 receptor agonist drugs protect against diabetic retinopathy, a common complication of diabetes that can lead to sight loss, suggests new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15-19 September) and published in the journal Pharmaceutics.